Protection of pancreatic beta cells against high glucose-induced toxicity by astaxanthin-s-allyl cysteine diester: alteration of oxidative stress and apoptotic-related protein expression

References

• Al-Bulish, M.S.M., et al., 2017. The defensive role of antioxidants astaxanthin against oxidative damage in diabetic rats injected with streptozotocin. Journal of food and nutrition research, 5, 191–196.
   Google Scholar
• Ambati, R.R., et al., 2014. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications-a review. Marine drugs, 12 (1), 128–152.
   PubMed Web of Science ®Google Scholar
• Bazyel, B., et al., 2019. In vitro evaluation of the effects of lycopene on caspase system and oxidative DNA damage in high-glucose condition. Pharmacognosy magazine, 15, 30.
   Web of Science ®Google Scholar
• Bensellam, M., et al., 2012. The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Molecular and cellular endocrinology, 364, 1–27.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-W., et al., 2011. High glucose promotes nascent nephron apoptosis via NF-kappaB and p53 pathways. American journal of physiology. renal physiology, 300 (1), F147–F156.
   PubMed Web of Science ®Google Scholar
• Cregan, S.P., et al., 1999. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. The journal of neuroscience, 19 (18), 7860–7869.
   PubMed Web of Science ®Google Scholar
• Duprez, J., et al., 2012. Protective antioxidant and antiapoptotic effects of ZnCl2 in rat pancreatic islets cultured in low and high glucose concentrations. PLOS one, 7 (10), e46831.
   PubMed Web of Science ®Google Scholar
• Evans, J.L., et al., 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes, 52 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Fiordaliso, F., et al., 2001. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes, 50 (10), 2363–2375.
   PubMed Web of Science ®Google Scholar
• Flores-López, L.A., et al., 2013. High glucose induces mitochondrial p53 phosphorylation by p38 MAPK in pancreatic RINm5F cells. Molecular biology reports, 40 (8), 4947–4958.
   PubMed Web of Science ®Google Scholar
• Forbes, J.M., et al., 2013. Glucose homeostasis can be differentially modulated by varying individual components of a western diet. The journal of nutritional biochemistry, 24 (7), 1251–1257.
   PubMed Web of Science ®Google Scholar
• Gunathilaka, T.L., et al., 2020. Antidiabetic potential of marine brown algae—a mini review. Journal of diabetes research, 2020, 1230218.
   PubMed Web of Science ®Google Scholar
• Haythorne, E., et al., 2019. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Nature communications, 10 (1), 1–17.
   PubMedGoogle Scholar
• Hu, S., et al., 2016. Fucoidan from Cucumaria frondosa inhibits pancreatic islets apoptosis through mitochondrial signaling pathway in insulin resistant mice. Food science and technology research, 22 (4), 507–517.
   Web of Science ®Google Scholar
• Kaneto, H., et al., 1999. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 48 (12), 2398–2406.
   PubMed Web of Science ®Google Scholar
• Kim, Y.J., Kim, Y.A., and Yokozawa, T., 2009. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. Journal of agricultural and food chemistry, 57 (19), 8793–8797.
   PubMed Web of Science ®Google Scholar
• Kover, K., et al., 2015. Osteocalcin protects pancreatic beta cell function and survival under high glucose conditions. Biochemical and biophysical research communications, 462 (1), 21–26.
   PubMed Web of Science ®Google Scholar
• Kowaltowski, A., Vercesi, A., and Fiskum, G., 2000. Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides. Cell death and differentiation, 7 (10), 903–910.
   PubMed Web of Science ®Google Scholar
• Lablanche, S., et al., 2011. Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin. Cell death & disease, 2, e134–e134.
   PubMed Web of Science ®Google Scholar
• Lai, T.-T., Yang, C.-M., and Yang, C.-H., 2020. Astaxanthin protects retinal photoreceptor cells against high glucose-induced oxidative stress by induction of antioxidant enzymes via the PI3K/Akt/Nrf2 pathway. Antioxidants, 9 (8), 729.
   Web of Science ®Google Scholar
• Lee, D.-H., Kim, C.-S., and Lee, Y.J., 2011. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food and chemical toxicology: an international journal published for the British industrial biological research association, 49 (1), 271–280.
   PubMed Web of Science ®Google Scholar
• Lee, H.-A., Lee, J.-H., and Han, J.-S., 2018. 2,7"-Phloroglucinol-6,6'-bieckol protects INS-1 cells against high glucose-induced apoptosis. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 103, 1473–1481.
   PubMed Web of Science ®Google Scholar
• Lin, X., Zhao, Y., and Li, S., 2017. Astaxanthin attenuates glutamate-induced apoptosis via inhibition of calcium influx and endoplasmic reticulum stress. European journal of pharmacology, 806, 43–51.
   PubMed Web of Science ®Google Scholar
• Lovis, P., et al., 2008. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes, 57 (10), 2728–2736.
   PubMed Web of Science ®Google Scholar
• Marchetti, P., et al., 2017. Pancreatic beta cell identity in humans and the role of type 2 diabetes. Frontiers in cell and developmental biology, 5, 55.
   PubMed Web of Science ®Google Scholar
• Mateos, R., Pérez-Correa, J.R., and Domínguez, H., 2020. Bioactive properties of marine phenolics. Marine drugs, 18 (10), 501.
   PubMed Web of Science ®Google Scholar
• Min, S.W., Park, M.H., and Han, J.S., 2014. Polyopes lancifolia extracts protect INS-1 pancreatic β cells against high glucose level induced apoptosis. Food science and biotechnology, 23 (2), 633–640.
   Web of Science ®Google Scholar
• Moon, J.S., et al., 2017. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells. Journal of diabetes and its complications, 31 (1), 21–30.
   PubMed Web of Science ®Google Scholar
• Ortega-Camarillo, C., et al., 2006. Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells. Molecular and cellular biochemistry, 281 (1–2), 163–171.
   PubMed Web of Science ®Google Scholar
• Park, M.H., and Han, J.-S., 2014. Padina arborescens extract protects high glucose-induced apoptosis in pancreatic β cells by reducing oxidative stress. Nutrition research and practice, 8 (5), 494–500.
   PubMed Web of Science ®Google Scholar
• Park, M.H., and Han, J.S., 2015. Phloroglucinol protects INS-1 pancreatic β-cells against glucotoxicity-induced apoptosis. Phytotherapy research, 29 (11), 1700–1706.
   PubMed Web of Science ®Google Scholar
• Park, M.-H., et al., 2015. 6,6'-Bieckol protects insulinoma cells against high glucose-induced glucotoxicity by reducing oxidative stress and apoptosis. Fitoterapia, 106, 135–140.
   PubMed Web of Science ®Google Scholar
• Penislusshiyan, S., et al., 2020. Novel antioxidant astaxanthin-s-allyl cysteine biconjugate diminished oxidative stress and mitochondrial dysfunction to triumph diabetes in rat model. Life sciences, 245, 117367.
   PubMed Web of Science ®Google Scholar
• Raúl, B.-G., et al., 2015. Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells. Molecular and cellular biochemistry, 405 (1–2), 257–264.
   PubMed Web of Science ®Google Scholar
• Renaud, J., et al., 2014. Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization. Neurotoxicity research, 25 (1), 110–123.
   PubMed Web of Science ®Google Scholar
• Robertson, R.P., 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. The journal of biological chemistry, 279 (41), 42351–42354.
   PubMed Web of Science ®Google Scholar
• Sakayanathan, P., et al., 2018. Biological interaction of newly synthesized astaxanthin-s-allyl cysteine biconjugate with Saccharomyces cerevisiae and mammalian α-glucosidase: In vitro kinetics and in silico docking analysis. International journal of biological macromolecules, 118 (Pt A), 252–262.
   PubMedGoogle Scholar
• Schuler, M., et al., 2000. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. The journal of biological chemistry, 275 (10), 7337–7342.
   PubMed Web of Science ®Google Scholar
• Sesti, G., 2002. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Annals of medicine, 34 (6), 444–450.
   PubMed Web of Science ®Google Scholar
• Tao, S., et al., 2017. Salvianolic acid B inhibits intermittent high glucose-induced INS-1 cell apoptosis through regulation of Bcl-2 proteins and mitochondrial membrane potential. European journal of pharmacology, 814, 56–62.
   PubMed Web of Science ®Google Scholar
• Tiedge, M., et al., 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 46 (11), 1733–1742.
   PubMed Web of Science ®Google Scholar
• Tomita, T., 2016. Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosnian journal of basic medical sciences, 16 (3), 162–179.
   PubMed Web of Science ®Google Scholar
• Uchiyama, K., et al., 2002. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox report: communications in free radical research, 7 (5), 290–293.
   PubMed Web of Science ®Google Scholar
• Volpe, C.M.O., et al., 2018. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell death & disease, 9 (2), 1–9.
   PubMedGoogle Scholar
• Wu, J., et al., 2017. Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes. Biochemistry and biophysics reports, 11, 119–129.
   PubMedGoogle Scholar
• Yang, Z., et al., 2015. 1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing. Molecular and cellular endocrinology, 414, 111–119.
   PubMed Web of Science ®Google Scholar
• Yin, X., et al., 2015. Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening. Journal of molecular endocrinology, 55 (3), 169–181.
   PubMed Web of Science ®Google Scholar
• Ying, C., et al., 2017. Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 90, 796–805.
   PubMed Web of Science ®Google Scholar
• Zhou, X., et al., 2017. Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway. Brain research bulletin, 132, 190–198.
   PubMed Web of Science ®Google Scholar